Prosecution Insights
Prosecution Insights
Tech Center 1600 • Art Units: 1648 1671
This examiner grants 64% of resolved cases
| App # | Title | Status | Assignee |
|---|---|---|---|
| 17817382 | HPV VACCINE | Non-Final OA | Merck Sharp & Dohme LLC |
| 17862240 | Methods for Viral Particle Characterization Using Two-Dimensional Liquid Chromatography-Mass Spectrometry | Non-Final OA | Regeneron Pharmaceuticals, Inc. |
| 17603789 | PHAGE TEST KIT | Non-Final OA | DSM IP Assets B.V. |
| 17310461 | CANCER SPECIFIC FRAMESHIFT VACCINES | Non-Final OA | Arizona Board of Regents on Behalf of Arizona State University |
| 18016932 | METHODS OF DIAGNOSTICS | Non-Final OA | TECHNION RESEARCH & DEVELOPMENT FOUNDATION LIMITED |
| 18624656 | FREEZE DRIED VIRAL NANOPARTICLE CONSTRUCTS | Non-Final OA | CASE WESTERN RESERVE UNIVERSITY |
| 17800687 | Multilamellar RNA Nanoparticles and Methods of Sensitizing Tumors to Treatment with Immune Checkpoint Inhibitors | Non-Final OA | UNIVERSITY OF FLORIDA RESEARCH FOUNDATION, INCORPORATED |
| 18256844 | ASSAYS FOR RAPID DETECTION OF AIRBORNE VIRUSES INCLUDING INFLUENZA AND CORONAVIRUSES | Non-Final OA | TELEDYNE FLIR DEFENSE, INC. |
| 17845629 | Methods and Systems for Detection of Covid Variants | Non-Final OA | Laboratory Corporation of America Holdings |
| 18229072 | SAMPLE PRETREATMENT KIT AND METHOD FOR DETECTING VIRUS INFECTIVITY | Final Rejection | Delta Electronics Int’l (Singapore) Pte Ltd |
| 18344952 | METHODS FOR DETERMINING SARS-COV-2 ANTIGEN AND ANTI-SARS-COV-2 ANTIBODY IN A SAMPLE | Final Rejection | Abbott Laboratories |
| 18503487 | Vaccines For Human Papilloma Virus And Methods For Using The Same | Final Rejection | Inovio Pharmaceuticals, Inc. |
| 18017073 | GDF-15 FOR PREDICTING THE DISEASE SEVERITY OF A PATIENT WITH COVID-19 | Non-Final OA | Roche Diagnostics Operations, Inc. |
| 18257889 | MULTIVALENT HVT VECTOR VACCINE | Final Rejection | INTERVET INC. |
| 18290356 | NOVEL PROTEIN AND NUCLEIC ACID SEQUENCES FOR COVID-19 VACCINES | Non-Final OA | Dompe' Farmaceutici SPA |
| 18281416 | MICROORGANISM DISPLAYING ANTIGENIC PROTEIN OF THE SARS-CoV2 CORONAVIRUS | Non-Final OA | LES BIOTECHNOLOGIES ULYSSE INC. |
| 17611063 | COMPOSITIONS AND METHODS FOR TREATING HEPATITIS B VIRUS (HBV) INFECTION | Final Rejection | Vir Biotechnology, Inc. |
| 17635537 | PHARMACEUTICAL COMPOSITIONS COMPRISING ONCOLYTIC HERPES SIMPLEX VIRUS FOR SYSTEMIC ADMINISTRATION | Non-Final OA | IMMVIRA CO., LIMITED |
| 18248861 | METHOD AND COMPOSITON FOR TREATING CANCER USING A VACCINE | Non-Final OA | HPVVAX, LLC |
| 18145772 | SARS-COV-2 SERUM ANTIBODY PROFILING | Non-Final OA | Serimmune Inc. |
| 17909688 | SYSTEMS AND METHODS FOR GENERATING IMMUNE RESPONSES IN SUBJECTS USING MICROCHANNEL DELIVERY DEVICES | Final Rejection | AQUAVIT PHARMACEUTICALS, INC. |
| 17790438 | POLYPEPTIDE ENCODED BY EB VIRUS BNLF2B GENE AND USE THEREOF IN DETECTION | Non-Final OA | BEIJING WANTAI BIOLOGICAL PHARMACY ENTERPRISE CO., LTD. |
| 17634526 | NOVEL TREATMENT AND PREVENTION OF DISEASE BASED ON IMMUNOLOGICAL MEMORY | Final Rejection | Zeria Pharmaceutical Co., Ltd. |
| 17675329 | TOPICAL APPLICATION FOR AN ANTI-HSV ANTIBODY | Final Rejection | Heidelberg ImmunoTherapeutics GmbH |
| 17611925 | RECOMBINANT BACULOVIRUS DISPLAYING AFRICAN SWINE FEVER VIRUS PROTEINS, AND AN IMMUNOLOGICAL COMPOSITION COMPRISING THE SAME | Final Rejection | Ming-Che Shih |
| 17442558 | VACCINATION USING HIGH-DENSITY MICROPROJECTION ARRAY PATCH | Final Rejection | Angus FORSTER |
IP Author analyzes examiner patterns and generates tailored response strategies with the highest chance of allowance.
Build Your Strategy